Platform capability
Each entry is a working definition for readers of these pages. It is not a legal definition and not a quotation from a standard. Where a standard exists, follow the standard.
Any untoward medical occurrence in a participant, whether or not it is considered related to the intervention.
A serious adverse event. Seriousness is not the same thing as severity or relatedness.
A suspected unexpected serious adverse reaction. Reporting clocks depend on the applicable rule.
Keeping one or more parties unaware of the assigned intervention.
Hiding the next assignment until the participant is enrolled. A predictable list breaks it.
Assigning interventions by a chance procedure written in advance.
Randomizing within categories so those categories stay balanced.
The treatment effect the study intends to estimate, including how intercurrent events are handled.
The variable used to judge an outcome.
The document that describes the objectives, design, methods and organization of a study.
A written change to the protocol after it has been approved.
An electronic case report form. A field value plus the history of changes.
A question about a data value. It does not itself change the value.
The original record of an observation. Verification compares the eCRF with it.
A signed decision that the analysis snapshot will not take further routine edits.
A checksummed copy of the data an analysis will use.
A CDISC model for tabulating collected data. A shaped file is not a certified submission.
A CDISC model for analysis data. Same caution as SDTM.
A CDISC document that describes the datasets. Schema validation is a separate step.
A CDISC guide for how data are commonly collected.
CDISC Operational Data Model, often used to describe forms.
The operational record of sites, visits, milestones and issues.
The system of record for case report form values.
The electronic trial master file of essential documents.
Randomization and trial supply management.
Interactive response technology used at the moment of allocation.
A consent process that records the version and the signatures. Legality depends on the jurisdiction and the approval.
An outcome reported by the participant on an electronic instrument.
Electronic clinical outcome assessment. Includes PRO, ClinRO, ObsRO and PerfO.
An outcome reported by a clinician.
An outcome reported by an observer who is not the participant.
An outcome based on a task the participant performs.
A patient-reported outcome.
Risk-based quality management. Effort follows prespecified risks.
A key risk indicator. A measurement, not a verdict.
A quality tolerance limit the team set for a critical factor.
Critical to quality. A factor that, if wrong, threatens participants or the result.
Corrective and preventive action. Effectiveness should be checked by someone else.
Oversight of the study, on site or centrally, written down by a person.
A departure from the approved process, recorded with a reason.
A record of who changed what, and when. It is not deleted to tidy a screen.
A signature bound to a person and to the hash of what they signed.
21 CFR Part 11, the US rule on certain electronic records and signatures. Controls are not a compliance claim.
The ICH guideline on good clinical practice.
The ICH guideline on statistical principles for clinical trials.
Good clinical practice. A set of duties. Software does not possess them.
A checklist for trial protocols.
A checklist and flow diagram for reporting randomized trials.
A checklist for observational studies.
A checklist for diagnostic accuracy studies.
A checklist for systematic reviews.
A checklist for reporting prediction models.
The international standard for clinical investigations of medical devices. Certification is separate.
The EU Medical Device Regulation. A legal text, not a software mode.
The EU In Vitro Diagnostic Regulation.
The EU Clinical Trials Information System. This product does not submit to it.
Investigational New Drug application in the United States.
Investigational Device Exemption in the United States.
Protected health information. Do not type it into a public form.
HL7 Fast Healthcare Interoperability Resources. A standard, not a certified interface.
A common data model published by OHDSI.
The standard file format for medical images.
The DICOM de-identification profile guidance. A local profile is not a certificate of conformance.
A licensed adverse-event dictionary. Not included in this product.
A licensed drug dictionary. Not included.
A licensed clinical terminology. Not included.
A code system for laboratory and clinical observations.
The International Classification of Diseases.
The organization that publishes CDASH, SDTM, ADaM, ODM and Define-XML.
CDISC CORE, a conformance engine. This product does not run it.
A widely used CDISC validation tool. This product does not run it.
The proportion of people with the condition who test positive, in a stated population.
The proportion of people without the condition who test negative.
A curve of true-positive against false-positive rates across thresholds.
A method for estimating the proportion still event-free over time, with censoring.
A regression for the hazard, under a proportional-hazards assumption.
A participant’s event time is only known to be after a date.
A sensitivity number for how strong an unmeasured confounder would need to be. Not a proof.
A modeled probability of receiving the exposure, used in observational analysis. It is not randomization.
Inverse probability weighting. A way to reweight observations. It depends on the model.
The probability of detecting a stated effect if the assumptions hold.
The problem of looking at many endpoints or many times.
An event after treatment starts that affects interpretation, such as discontinuation.
A person who was screened and not enrolled.
The list of who may do which study task.
A document that allows the conduct of the study and the quality of the data to be evaluated.
Trial master file.
Clinical study report. ICH E3 describes its structure. The software does not emit a finished one.
A data and safety monitoring board. The software does not sit on it.
Revealing an assignment. It should be exceptional and signed.
A packaged investigational product with an identity and a status.
Unique device identifier.
A temperature or handling event outside the labeled range. A person records it.
A statement of where a value came from and what was done to it.
A hash of bytes, so a later reader can see whether they changed.
An organization whose data are not visible to another organization by default.
An organization allowed to hold only synthetic participants.
The list of actions an API key is allowed to perform.
An outbound call to an address you named. Private addresses are refused.
Documented evidence that a system meets its requirements. A deploy is not a validation.
A download of quality tables. Not an inspection certificate.
Invented records used for demonstration. They are not participants.
The party that takes responsibility for starting and managing a study, as defined by the applicable rule.
A contract research organization acting for a sponsor under a written scope.
The person responsible for the conduct of the study at a site.
A person’s voluntary decision after being informed. The version and the signature are the record.
Because the content is licensed. The name and the limitation are enough.
Available with limitations means the described software behavior exists. A professional service is work a person does under a separate scope. Nothing here is a certification.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU